Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 130, Issue 8, 2004, Pages 475-479

  Nakashima, Masanao ^a   Ohike, Nobuyuki ^a   Nagasaki, Koichi ^b   Adachi, Mitsuru ^a   Morohoshi, Toshio ^a  

^a SHOWA UNIVERSITY   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

Immunohistochemistry; Maspin; Prognosis; Pulmonary adenocarcinoma; Tumor suppressor gene

Indexed keywords

MASPIN;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

EID: 4344669925     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0571-x     Document Type: Article

References (24)

1. American Joint Committee on Cancer (2002) Cancer staging handbook. TMN classification of malignant tumors, 6th edn. Springer, New York, pp 191-203
2. Bepler G, Goodridge Carney D, Djulbegovic B, Clark RA, Tockman M (2003) A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. Cancer Control 10:306-314
3. Boring CC, Squires TS, Tong T (1993) Cancer statistics. Cancer J Clin 43:7-26
4. Chiba Y, Taniguchi T, Matsuyama K, Sasaki M, Kato Y, Tanaka H, Muraoka R, Tanigawa N (1999) Tumor angiogenesis, apoptosis, and p53 oncogene in stage I lung adenocarcinoma. Surg Today 29:1148-1153
5. Hirabayashi H, Ohta M, Tanaka H, Sakaguchi M, Fujii Y, Miyoshi S, Matsuda H (2002) Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53. J Surg Oncol 81:177-184
6. Kuroishi T, Nishikawa Y, Tominaga S, Aoki K (1999) Cancer mortality statistics in 33 countries (1954-1992). Gann monograph on cancer research: cancer mortality and morbidity statistics, vol 47. Japan Scientific Societies, Tokyo Karger Basel, pp 153-217
7. Luppi M, Morselli M, Bandieri E, Federico M, Marasca R, Barozzi P, Ferrari MG, Savarino M, Frassoldati A, Torelli G (1996) Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol 7:619-624
8. Maass N, Hojo T, Ueding M, Lüttges J, Klöppel G, Jonat W, Nagasaki K (2001a) Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res 7:812-817
9. Maass N, Hojo T, Rosel F, Ikeda T, Jonat W, Nagasaki K (2001b) Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 34:303-307
10. Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Nagasaki K, Rudolph P (2001c) Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 195:321-326
11. Machtens S, Serth J, Bokemeyer C, Bathke W, Minssen A, Kollmannsberger C, Hartmann J, Knuchel R, Kondo M, Jonas U, Kuczyk M (2001) Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 95:337-342
12. Ohike N, Maass N, Mundhenke C, Biallek M, Zhang M, Jonat W, Lüttges J, Morohoshi T, Klöppel G, Nagasaki K (2003) Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett 199:193-200
13. Oh YL, Song SY, Ahn G (2002) Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis. Appl Immunohistochem Mol Morphol 10:62-66
14. Sasaki M, Sugio K, Kuwabara Y, Koga H, Nakagawa M, Chen T, Kaneko K, Hayashi K, Shioyama Y, Sakai S, Honda H (2003) Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer. Ann Nucl Med 17:189-196
15. Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R, Hendrix MJ (1998) Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 58:5681-5685
16. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA, Hendrix MJ (2002) The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8:2924-2932
17. Tomizawa Y, Kohno T, Kondo H, Otsuka A, Nishioka M, Niki T, Yamada T, Maeshima A, Yoshimura K, Saito R, Minna JD, Yokota J (2002) Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res 8:2362-2368
18. Travis WD, Travis LB, Devesa SS (1995) Lung cancer. Cancer 75:191-202
19. Wang B, Yan C, Wu Y, Gao H, Wang Q, Jin Y, Huang C, Zhang G, Fu S, Li P (2001) Expression of tumor suppressor genes p16, p21 and p53 in a pair of lung adenocarcinoma cell lines with different metastasis potentials: Anip973 and AGZY83-a. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18:128-131
20. Xia W, Lau YK, Hu MC, Li L, Johnston DA, Sheng S, El-Naggar A, Hung MC (2000) High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 19:2398-2403
21. Yasumatsu R, Nakashima T, Hirakawa N, Kumamoto Y, Kuratomi Y, Tomita K, Komiyama S (2001) Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 23:962-966
22. Zhang M, Volpert O, Shi YH, Bouck N (2000) Maspin is an angiogenesis inhibitor. Nat Med 6:196-199
23. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526-529
24. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S (2000) p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275:6051-6054